Skip to content

Effect of Individualized Homoeopathic Medicines selected through Complete Repertory on Recurrence and Immunoglobulin Levels in Patients with Recurrent Urinary Tract Infections

A study to evaluate the effectiveness of homoeopathic medicines selected using complete repertory in cases of recurrent Urinary Tract Infections and to see the corresponding changes in IgG and IgM levels: a open label pre -post interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097378
Enrollment
42
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Indicated individualized homoeopathic medicine will be prescribed after the repertorisation of the case using rubrics within complete repertory.Fol

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining with burning sensation during micturation either continuously for the past 6 mon ths or occurring 2 to 3 times over the last 6 months to 1 year diagnosed by Urine RE and ME and Urine culture willing to further undergo necessary investigation during treatment and follow up. Patients between 18-65 years age group ,from any socio-economic status,able to understand Bengalior Hindi or English and willing to give informed consent to volunteer for the study .

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mothers. 2.Complicated cases of Recurrent UTIs(urosepsis,chronic pyelonephritis,septicemia etc.) 3.Cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness.

Design outcomes

Primary

MeasureTime frame
To asses the change in UTI-SIQ-8 scaleTimepoint: Baseline and 6 months

Secondary

MeasureTime frame
To asess the change in IgG and IgM Levels . Recording the Adverse drug reaction if occur during the study periodTimepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactDr Lokanath Behera

National Institute Of Homoeopathy,Kolkata

lokanath.behera@yahoo.in9477747610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026